Suppr超能文献

病毒血清学与检测

Viral serology and detection.

作者信息

Greer S, Alexander G J

出版信息

Baillieres Clin Gastroenterol. 1995 Dec;9(4):689-721. doi: 10.1016/0950-3528(95)90057-8.

Abstract

Viral detection is an important part of clinical hepatology. For many years practical clinical tests have been serological but recently newer molecular techniques have become available for virus detection, although these have yet to become routine and some, such as PCR of viral nucleic acid in blood or tissue are not yet consistently reliable. Serology remains the mainstay at present for routine diagnosis. Hepatitis A testing in clinical practice is entirely serological, the IgM response representing acute infection and the IgG response immunity, although more sophisticated molecular techniques have been applied experimentally. A second agent of epidemic enteral hepatitis, the hepatitis E virus, has recently been cloned and sequenced and serological tests for this virus are available, although experience in their use is necessarily limited and a commercial IgM assay has yet to be produced. Serological tests for the hepatitis B virus are well developed. The IgM anticore response differentiates acute infection from chronic, the latter being characterized by the persistence of hepatitis B surface antigen for over six months. Chronic carriers are at risk of liver damage and this risk is best assessed by the amount of viral DNA circulating, which can be determined using a hybridization assay. More sensitive techniques such as the branched chain DNA assay or PCR can detect lower levels of viral DNA but their clinical relevance remains to be established. The hepatitis D virus is defective and relies on hepatitis B to replicate. Serology for antibody and antigen is well established although PCR for circulating viral genome may come to supplant hepatic viral antigen as a test for hepatitis D replication. For hepatitis C serology is feasible only for antibodies, not antigens; although early tests were prone both to false positives and false negatives, current versions are more reliable. PCR has been much used for detection of hepatitis C RNA in blood and tissues and a bDNA assay is now commercially available. Cytomegalovirus detection is confounded by the problem of distinguishing asymptomatic viral replication from disease. Serology is helpful, especially in primary infections, but viral culture is a widely used method. PCR (especially quantitative modifications) or the pp65 antigenaemia assay are experimental approaches which may prove specific enough for general use.

摘要

病毒检测是临床肝病学的重要组成部分。多年来,实际临床检测一直采用血清学方法,但最近出现了更新的分子技术用于病毒检测,尽管这些技术尚未成为常规方法,而且一些技术,如血液或组织中病毒核酸的PCR检测,仍不够稳定可靠。血清学目前仍是常规诊断的主要手段。临床实践中甲型肝炎检测完全依靠血清学,IgM反应代表急性感染,IgG反应代表免疫,尽管更先进的分子技术已在实验中应用。流行性肠道肝炎的另一种病原体——戊型肝炎病毒,最近已被克隆和测序,针对该病毒的血清学检测方法也已出现,不过其使用经验必然有限,且尚未有商业化的IgM检测试剂盒。乙型肝炎病毒的血清学检测方法已很成熟。IgM抗核心抗体反应可区分急性感染和慢性感染,慢性感染的特征是乙肝表面抗原持续存在超过6个月。慢性携带者有肝损伤风险,这种风险最好通过循环病毒DNA的量来评估,可使用杂交检测法测定。更敏感的技术,如分支链DNA检测法或PCR,可检测到更低水平的病毒DNA,但其临床相关性仍有待确定。丁型肝炎病毒有缺陷,依赖乙型肝炎病毒进行复制。抗体和抗原的血清学检测方法已很成熟,尽管用于检测循环病毒基因组的PCR可能会取代肝病毒抗原检测,成为丁型肝炎病毒复制的检测方法。对于丙型肝炎,血清学检测仅适用于抗体,不适用于抗原;尽管早期检测容易出现假阳性和假阴性,但目前的检测版本更可靠。PCR已广泛用于检测血液和组织中的丙型肝炎病毒RNA,现在有一种分支链DNA检测法已商业化。巨细胞病毒检测因难以区分无症状病毒复制和疾病而受到困扰。血清学检测有帮助,尤其是在原发性感染中,但病毒培养是一种广泛使用的方法。PCR(特别是定量改进方法)或pp65抗原血症检测是实验性方法,可能会被证明特异性足够高,可广泛应用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验